Private equity giant Blackstone is said to be nearing a deal to buy pharmaceuticals and regulatory consulting business Advarra from Genstar Capital at $5bn valuation. The post Blackstone near deal to buy Advarra from Genstar
Global buyout giant Blackstone has agreed to acquire Australian clinical trials provider Nucleus Network. The post Blackstone to acquire Australian clinical trials provider Nucleus Network eyeing increasing demand from offshore biotech companies first appeared on
Private equity titan Carlyle has backed clinical trial data management business Saama Technologies to expand its go-to-market capabilities and further investment in AI research and development. The post Carlyle buys into AI-embedded clinical trial data
